Related Experiment Videos

Transcriptomic identification of key genes influencing m7G modification in thyroid carcinoma and experimental

Bo Li1,2, Liying Zhu3, Jiewu Zhang4

  • 1Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, No.150 Haping Road, Nangang District, Harbin, 150040, Heilongjiang, China.

Discover Oncology
|June 22, 2026
PubMed
Abstract

Insights

N7-methylguanosine (m7G) modification and its related gene ZNF831 show potential as therapeutic targets in thyroid carcinoma (THCA). This study identified ZNF831 as a tumor suppressor that reduces THCA cell proliferation and migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • N7-methylguanosine (m7G) modification is crucial for RNA metabolism and increasingly linked to cancer biology.
  • Its specific role and downstream genes in thyroid carcinoma (THCA) remain largely unexplored.
  • Understanding m7G modification's impact on THCA is vital for advancing cancer research.

Purpose of the Study:

  • To investigate the role of m7G modification and the m7G-related gene ZNF831 in thyroid carcinoma (THCA).
  • To identify key genes influencing m7G modification in THCA.
  • To elucidate the pathological mechanisms of THCA and ZNF831's function.

Main Methods:

  • Weighted gene co-expression network analysis (WGCNA) on GEO datasets.
  • Machine learning algorithms (LASSO, XGBoost, RF) to identify feature genes (GPSM3, ZNF831) in TCGA-THCA data.
  • Immunohistochemistry and cell-based assays to validate ZNF831's role in THCA proliferation and migration.

Main Results:

  • Significant dysregulation of m7G-related genes observed in THCA.
  • ZNF831 identified as a key tumor suppressor gene.
  • Overexpression of ZNF831 significantly inhibited THCA cell proliferation and migration.
  • Positive correlation between ZNF831 expression and anti-tumor immune cell infiltration found.

Conclusions:

  • m7G modifications and ZNF831 are important in THCA pathogenesis.
  • ZNF831 demonstrates potential as a therapeutic target in THCA.
  • Further research is warranted to explore molecular mechanisms and clinical applications.